The Association Between BRAF Mutation Class and Clinical Features in BRAF-Mutant Chinese Non-Small Cell Lung Cancer Patients

被引：0
|
作者：
Lin, Q. [1 ]
Zhu, H. [2 ]
Li, Y. [1 ]
Zhang, H. [3 ]
Ding, H. [4 ]
Qian, J. [5 ]
Han-Zhang, H. [6 ]
Lin, J. [6 ]
Xiang, J. [6 ]
机构：
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Wenzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
[3] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China
[4] Ningbo Diagnost Pathol Ctr, Ningbo, Zhejiang, Peoples R China
[5] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou, Peoples R China
[6] Burning Rock Biotech, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Chinese; braf; NSCLC;
D O I：
10.1016/j.jtho.2019.08.735
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-20
引用
收藏
页码：S363 / S363
页数：1
相关论文
共 50 条
  • [21] Ongoing Progress in BRAF-Mutated Non-Small Cell Lung Cancer
    Abdayem, Pamela
    Planchard, David
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (11) : 662 - +
  • [22] Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
    Rosell, Rafael
    Gonzalez-Cao, Maria
    Codony-Servat, Jordi
    Molina-Vila, Miguel Angel
    Mayo de las Casas, Clara
    Ito, Masaoki
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (03) : 456 - 460
  • [23] Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSe Trial
    Mazieres, Julien
    Cropet, Claire
    Barlesi, Fabrice
    Souquet, Pierre Jean
    Avrillon, Virginie
    Coudert, Bruno
    Le Treut, Jacques
    Piocelle, Frederique Orsini
    Quere, Gilles
    Fabre, Elizabeth
    Tredaniel, Jean
    Wislez, Marie
    Huillard, Olivier
    Dansin, Eric
    Moro-Sibilot, Denis
    Blons, Helene
    Ferretti, Gilbert
    Lonchamp, Etienne
    Labouret, Natalie Hoog
    Pezzella, Veronica
    Oukhatar, Celine Mahier Ait
    Blay, Jean-Yves
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1182 - S1183
  • [24] BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?
    Caparica, Rafael
    de Castro, Gilberto, Jr.
    Gil-Bazo, Ignacio
    Caglevic, Christian
    Calogero, Raffaele
    Giallombardo, Marco
    Santos, Edgardo S.
    Raez, Luis E.
    Rolfo, Christian
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 101 : 32 - 39
  • [25] Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer
    Nicos, Marcin
    Krawczyk, Pawel
    Jarosz, Bozena
    Sawicki, Marek
    Szumillo, Justyna
    Trojanowski, Tomasz
    Milanowski, Janusz
    CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 16 (02) : 169 - 176
  • [26] Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer
    Marcin Nicoś
    Paweł Krawczyk
    Bożena Jarosz
    Marek Sawicki
    Justyna Szumiłło
    Tomasz Trojanowski
    Janusz Milanowski
    Clinical and Experimental Medicine, 2016, 16 : 169 - 176
  • [27] A meta-analysis of the association between BRAF mutation and nonsmall cell lung cancer
    Cui, Guanghui
    Liu, Donglei
    Li, Weihao
    Fu, Xiao
    Liang, Youguang
    Li, Yuhang
    Shi, Wensong
    Chen, Xiaofang
    Zhao, Song
    MEDICINE, 2017, 96 (14)
  • [28] A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
    Baik, Christina
    Cheng, Michael L.
    Dietrich, Martin
    Gray, Jhanelle E.
    Karim, Nagla A.
    ADVANCES IN THERAPY, 2024, 41 (07) : 2586 - 2605
  • [29] Clinical features and therapeutic options in non-small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF
    Zhuang, Xibin
    Zhao, Chao
    Li, Jiayu
    Su, Chunxia
    Chen, Xiaoxia
    Ren, Shengxiang
    Li, Xuefei
    Zhou, Caicun
    CANCER MEDICINE, 2019, 8 (06): : 2858 - 2866
  • [30] The evolving treatment landscape for BRAF-mutated non-small cell lung cancer
    Dankner, Matthew
    Maxwell, Jennifer
    Rose, April A. N.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (04) : 930 - 935
12345